From photosensitivity to autoimmunity: the role of AI metabolomics in PCT-celiac disease overlap.

Genetic traits and diet triggering the iron-induced hepatic model of the idiopathic disorder sporadic porphyria cutanea tarda.

Porphyria cutanea tarda in children: epidemiological study of a rare disease in Argentina.

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.

Responses to 'Responses to "red fluorescence in porphyria cutanea tarda"'.

Stability of plasma and erythrocyte porphyrins: implications for diagnosis and monitoring of erythropoietic protoporphyria.

Persistent Beetroot Colored Urine in a Three-Year-Old Child: A Case Report.

Responses to 'Red fluorescence in porphyria cutanea tarda'.

[Porphyria cutanea tarda and hepatitis C infection].

[Porphyria cutanea tarda].

Red fluorescence in porphyria cutanea tarda.

Dorsal Hand Involvement in Porphyria Cutanea Tarda.

Porphyria Cutanea Tarda: A Multifactorial Disease.

Part I. Dermatologic Manifestations in Patients with Kidney Disease.

Atypical Presentation of Homozygous UROD Mutation: Porphyria Cutanea Tarda or Mild Hepatoerythropoietic Porphyria?

Porphyria Cutanea Tarda: A Phenotypic Expression of Several Genes.

Porphyria cutanea tarda and systemic lupus erythematosus: a case report.

Unique Dermatological and Systemic Manifestations in a Classic Pediatric Case of Kindler Syndrome: A Case Report and Literature Review.

Sporadic Porphyria Cutanea Tarda, Cutaneous Sarcoidosis, and Compound Heterozygosity of HFE Mutations Cys282Tyr and His63Asp-A Case Report.

Skin Manifestations Among Individuals With Hepatitis C Infection.

Treatment of Porphyria Cutanea Tarda Scarring With Combination Laser Treatment and a Pilot Use of Artificial Intelligence to Quantify Laser Results.

The risk of skin infections in end-stage renal disease patients with porphyria cutanea tarda: A retrospective cohort study.

Enhanced cardiovascular risks in patients with porphyria Cutanea Tarda: A retrospective cohort study.

Milia within resolving bullous pemphigoid lesions.

Porphyria cutanea tarda: a unique iron-related disorder.

Porphyria Cutanea Tarda in a Patient With Hereditary Hemochromatosis: A Complex Overlap Disorder.

Porphyria cutanea tarda triggered by hepatitis-E virus.

Nail Bed Regeneration by Excision of Distal Scarred Matrix in a Patient with Porphyria Cutanea Tarda.

Anogenital Erosive Lichen Sclerosus in a Male With Multiple Autoimmune Conditions.

Novel UROD mutation for porphyria cutanea tarda, type 2: a case report.

Atypical presentation of pellagra with black urine: A clinical conundrum.

Clinical Characteristics and Inciting Agents for Pseudoporphyria: The Mayo Clinic Experience, 1996-2020.

A rare case of porphyria cutanea tarda in a patient with a homozygous hereditary hemochromatosis gene H63D mutation in the setting of hereditary hemochromatosis.

Practical recommendations for biochemical and genetic diagnosis of the porphyrias.

Vesiculobullous skin lesions on the hands and face.

[An overview of porphyrias].

The clinical management of porphyria cutanea tarda: An update.

Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs.

Dermatologic manifestations of hereditary hemochromatosis: A systematic review.

Drug-Induced Pseudoporphyria: A Case Report.

Porphyria cutanea tarda in Scotland: underlying associations and treatment approaches.

Extrahepatic Manifestations of Chronic Hepatitis C Virus (HCV) Infection.

IgM-mediated epidermolysis bullosa acquisita.

Dermatological Manifestations in Patients With Chronic Kidney Disease: A Review.

Porphyria cutanea tarda in a human immunodeficiency virus-positive patient.

Comments and illustrations of the WFUMB CEUS liver guidelines: Peliosis hepatis and porphyria.

Acute Porphyria: An Unusual Case Of Quadriparesis, Hypertension, Recurrent Severe Cyclic Abdominal Pain, And Seizures.

Porphyria cutanea tarda: an under-recognised manifestation of haemochromatosis.

Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis.

Update on the Porphyrias.

A Rare Case of Hereditary Hemochromatosis Presenting With Porphyria Cutanea Tarda.

Control of porphyria cutanea tarda with anti-IL-17 secukinumab in a person with psoriasis living with HIV.

Porphyria Cutanea Tarda in a Patient with Myelofibrosis.

Case Report: Treatment of porphyria cutanea tarda with low dose hydroxychloroquine.

[Case of multiple systemic (extrahepatic) manifestations of chronic HCV infection (analysis of the literature and own observations). Case report].

A Case Report of Porphyria Cutanea Tarda with Hepatitis-C Virus Co-infection.

A Reversible Cause of Cutaneous Rash in a Patient With Alcohol Consumption.

Dusky pink annular plaques with a vesicular border.

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.

Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?

Bullosis diabeticorum as a differential diagnosis for limb ulcers: case report.

Renal Transplantation Could Reverse Dialysis-Associated Porphyria.

Iron Metabolism in the Disorders of Heme Biosynthesis.

Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias.

[Asthenia, weight loss in a 55 year-old woman].

When Simple Phlebotomy Is the Cure: Porphyria Cutanea Tarda.

Case 304: Porphyria Cutanea Tarda.

Skin Changes in Cirrhosis.

Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review.

Epidermolysis bullosa acquisita.

Psychological Aspect and Quality of Life in Porphyrias: A Review.

Porphyria cutanea tarda treated with short-term high-dose hydroxychloroquine: a case report.

Between a rock and a hard place: management of systemic lupus erythematosus and porphyria cutanea tarda.

Forearm porphyrin levels evaluated by digital imaging system are increased in patients with systemic sclerosis compared with patients in pre-clinical stage.

Porphyria cutanea tarda and patterns of long-term sick leave and disability pension: a 24-year nationwide matched-cohort study.

Not Only Skin Deep-A Rare Case of Porphyria Cutanea Tarda With Corneal Opacity Presenting Along With Scleroderma With Interstitial Lung Disease.

Facial hyperpigmentation and crusted papules on the hands.

Multiple focal fatty changes in the liver in patients with porphyria cutanea tarda: A case series and review of the literature.

The historical differential diagnosis of the disease that afflicted Aleijadinho, the famous 18th century Brazilian sculptor.

Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19.

The effects of alcohol and illicit drug use on the skin.

Sight-threatening progressive corneo-scleral involvement in porphyria cutanea tarda.

Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.

Alopecia Porphyrinica in a Patient with Chronic Hepatitis C.

The second Japanese case of porphyria cutanea tarda with a novel genetic mutation in UROD.

University of British Columbia Rural and Remote Dermatology Telemedicine Service: A Case of Porphyria Cutanea Tarda.

Iatrogenic Iron Overload Causing Porphyria Cutanea Tarda in a Patient With a Rare Nonsense Heterozygous UROD Gene Mutation.

[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].

Metastases-Like Liver Lesions in Two Different Types of Porphyria - Porphyria Cutanea Tarda (PCT) and Acute Hepatic Porphyria (AHP) - and the Role of CEUS.

Acquired erythropoietic uroporphyria secondary to myeloid malignancy: A case report and literature review.

Porphyria Cutanea Tarda Associated with Hepatitis C.

Scleral Compromise in Hereditary Porphyria Cutanea Tarda.

Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?

Porphyria: awareness is the key to diagnosis!

Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation.

Porphyria cutanea tarda precipitated by ovarian stimulation during oocyte retrieval in a genetically susceptible female.

Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda.

Porphyria Cutanea Tarda Masquerading as Systemic Sclerosis: Two Cases Demonstrating an Important Clinical Observation.

Role of ABCB1 and glutathione S-transferase gene variants in the association of porphyria cutanea tarda and human immunodeficiency virus infection.

Porphyria cutanea tarda presenting as a lichenoid eruption.

Acute Intermittent Porphyria in a Man with Dual Enzyme Deficiencies.

Kidney transplantation improves the clinical outcomes of Acute Intermittent Porphyria.

Early presentation of adult-onset conditions: A dual diagnosis of hereditary hemochromatosis and porphyria cutanea tarda.

Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.

Porphyria cutanea tarda associated with nitrofurantoin: A unique drug reaction.

Diagnostic and therapeutic strategies for porphyrias.

Multiple milia formation in blistering diseases.

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy.

Porphyria cutanea tarda associated with elevated serum ferritin, iron overload, and a bone morphogenetic protein 6 genetic variant.

Indurated Skin and Iron Overload-the Missing Link.

Porphyria Cutanea Tarda Due to Primary Hemochromatosis.

Sporadic Porphyria Cutanea Tarda as the Initial Manifestation of Hereditary Hemochromatosis.

Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct-acting anti-virals.

A Case-Based Review of Iron Overload With an Emphasis on Porphyria Cutanea Tarda, Hepatitis C, C282Y Heterozygosity, and Coronary Artery Disease.

Health-related quality of life in porphyria cutanea tarda: a cross-sectional registry based study.

Secondary hemosiderosis presented by porphyria cutanea tarda in a kidney dialysis patient: A case report.

Intrahepatic Cholangiocarcinoma Associated with High Procalcitonin, Hypercalcemia, Polycythemia and Leukocytosis.

A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.

Pseudoporphyria induced by ultraviolet radiation.

Chronic blistering rash on hands.

Successful evolution of morphea after hepatitis C virus eradication with direct-acting antiviral agent treatment.

An unusual bullous eruption: olanzapine induced pseudoporphyria.

Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C.

Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn´s Disease.

Grover's Disease in a Kidney Transplant Recipient.

Unsafe Deposits: Overlapping Cutaneous Manifestations of Porphyria Cutanea Tarda, Ochronosis, Hemochromatosis, and Argyria.

Increased mortality in patients with porphyria cutanea tarda-A nationwide cohort study.

Do We Utilize Our Knowledge of the Skin Protective Effects of Carotenoids Enough?

Heme biosynthesis and the porphyrias.

A first report of porphyria cutanea tarda successfully treated with glycyrrhizin.

Epidemiology of cutaneous porphyria in Israel: a nationwide cohort study.

Porphyria Cutanea Tarda Associated With Acute Hemorrhagic Pancreatitis.

Letters from Botswana: Photosensitive Eruption in an HIV-Positive Patient.

Porphyria Cutanea Tarda Presenting as Erythema-multiforme Like Lesions.

Porphyria Cutanea Tarda-like Lesions in a Child With a Hepatic Disease.

Association between hepatitis C virus and porphyria cutanea tarda.

Clinical Guide and Update on Porphyrias.

Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir.

Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.

The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.

A 56-year-old male with porphyria cutanea tarda.

Experience in management of porphyria cutanea tarda in a tertiary referral Brazilian hospital from 2002 to 2017.

Feasibility of cellular bioenergetics as a biomarker in porphyria patients.

Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapies.

[The cutaneous porphyrias].

Porphyria cutanea tarda: Recent update.

Porphyria cutanea tarda: a case report.

[Recognize rare diseases on the skin].

Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.

The first Japanese case of familial porphyria cutanea tarda diagnosed by a UROD mutation.

[Porphyria cutanea tarda. Case report].

Use HFR-supra for porphyria cutanea tarda treatment in hemodialysis patient.

Improvement of porphyria cutanea tarda following treatment of hepatitis C virus by direct-acting antivirals: A case report.

Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.

Blisters on the sun-exposed area: as a clue for underlying hepatitis C virus infection.

[Porphyrias-what is verified?].

Porphyrias and photosensitivity: pathophysiology for the clinician.

New-Onset Blistering Eruption in a Young Child.

Non-familial porphyria cutanea tarda: a rare disease.

Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria.

Porphyria Cutanea Tarda Improvement With Elbasvir/Grazoprevir in End-Stage Renal Disease.

A new UROD mutation in childhood porphyria cutanea tarda after allogeneic stem cell transplantation for β-thalassemia major.

Role of Vitamin C in Skin Diseases.

Furosemide-induced pseudoporphyria in a patient with chronic kidney disease: case report.

Blistering of the hands following a manicure at a nail salon.

Porphyria Cutanea Tarda Presenting with Scleroderma, Ichthyosis, Alopecia, and Vitiligo.

Hepatitis C virus core protein triggers abnormal porphyrin metabolism in human hepatocellular carcinoma cells.

[Sclerodermatous changes revealing porphyria cutanea tarda].

Pseudo porphyria or porphyria cutanea tarda?

Porphyria cutanea tarda presenting as milia and blisters.

SLC40A1 and CP single nucleotide polymorphisms in porphyria cutanea tarda patients of mixed ancestry.

Hyperpigmented Patches on the Dorsal Hands.

Relapse of porphyria cutanea tarda after treatment with phlebotomy or 4-aminoquinoline antimalarials: a meta-analysis.

Blisters, Sores and Scars on the Dorsal Hands in a 17-year-old Girl: A Quiz.

Porphyria and kidney diseases.

Genetic ancestry of patients with porphyria cutanea tarda in a country with mixed races: a cross-sectional study (Rio de Janeiro - Brazil).

The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.

Photosensitive disorders in HIV.

Porphyria: What Is It and Who Should Be Evaluated?

Diagnosing diabetes mellitus in patients with porphyria cutanea tarda.

[Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a case report].

Urinary metabolic profiling of asymptomatic acute intermittent porphyria using a rule-mining-based algorithm.

Total Corneal Melt in Patient with Porphyria Cutanea Tarda in Presence of Another Risk Factor.

Bullosis Diabeticorum: A Rare Presentation with Immunoglobulin G (IgG) Deposition Related Vasculopathy. Case Report and Focused Review.

An overview of the cutaneous porphyrias.

Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.

Elderly Man With Bullous Eruption on the Feet.

Blisters, ulcers, crusts, and atrophic scars on the back of the hands and the extensor aspects of the forearms.

Bullous lesions in a haemodialysis patient.